FDA Class II Drug Recall: Acme United Corporation
Summary
The FDA has announced an ongoing Class II drug recall initiated by Acme United Corporation for Med Nap BZK Antiseptic Towelettes. The recall is due to CGMP deviations and affects nationwide distribution within the United States.
What changed
The U.S. Food and Drug Administration (FDA) has reported an ongoing Class II drug recall initiated voluntarily by Acme United Corporation. The recall concerns Med Nap BZK Antiseptic Towelettes (Benzalkonium Chloride 0.13%) due to Current Good Manufacturing Practice (CGMP) deviations. The affected product was distributed nationwide within the United States.
Companies involved in drug manufacturing should be aware of this recall and the reasons cited (CGMP deviations). While this is a voluntary recall, it highlights the importance of adhering to manufacturing standards. Compliance officers should review their internal CGMP practices and ensure robust quality control measures are in place to prevent similar issues. No specific compliance deadline is mentioned for other entities, but the recall itself is ongoing.
What to do next
- Review internal CGMP practices for antiseptic towelettes
- Ensure robust quality control measures are in place
Source document (simplified)
json
{
"meta": {
"disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
"terms": "https://open.fda.gov/terms/",
"license": "https://open.fda.gov/license/",
"last_updated": "2026-03-18",
"results": {
"skip": 0,
"limit": 1,
"total": 1
}
},
"results": [
{
"status": "Ongoing",
"city": "Shelton",
"state": "CT",
"country": "United States",
"classification": "Class II",
"openfda": {
"application_number": [
"M003"
],
"brand_name": [
"MED NAP BENZALKONIUM CHLORIDE ANTISEPTIC"
],
"generic_name": [
"BENZALKONIUM CHLORIDE"
],
"manufacturer_name": [
"Acme United Corporation"
],
"product_ndc": [
"0924-0246"
],
"product_type": [
"HUMAN OTC DRUG"
],
"route": [
"TOPICAL"
],
"substance_name": [
"BENZALKONIUM CHLORIDE"
],
"spl_id": [
"2682a042-f9ba-30dc-e063-6394a90a9e33"
],
"spl_set_id": [
"d7c404c1-c765-a67c-e053-2995a90a6b8e"
],
"package_ndc": [
"0924-0246-00",
"0924-0246-01",
"0924-0246-02",
"0924-0246-03"
],
"is_original_packager": [
true
],
"upc": [
"0092265940061"
],
"unii": [
"F5UM2KM3W7"
]
},
"product_type": "Drugs",
"event_id": "98291",
"recalling_firm": "ACME UNITED CORPORATION",
"address_1": "1 Waterview Dr Ste 200",
"address_2": "N/A",
"postal_code": "06484-4368",
"voluntary_mandated": "Voluntary: Firm initiated",
"initial_firm_notification": "Letter",
"distribution_pattern": "Nationwide within the United States",
"recall_number": "D-0366-2026",
"product_description": "Med Nap BZK Antiseptic Towelettes (Benzalkonium Chloride 0.13%), 100 Towelettes, Manufactured by: Acme United Corporation, 1 Waterview Dr, Shelton, CT 06481, NDC 0924-0246-01.",
"product_quantity": "N/A",
"reason_for_recall": "CGMP Deviations",
"recall_initiation_date": "20260120",
"center_classification_date": "20260302",
"report_date": "20260311",
"code_info": "Lot #: MN09322, Exp. Date Mar 2027; MN15222, Exp. Date May 2027; MN21622, Exp. Date Jul 2027; MN31822, Exp. Date Oct 2027; MN06223, MN06323, Exp. Date Feb 2028; MN12523, Exp. Date Apr 2028; MN16123, Exp. Date May 2028; MN20523, MN20623, MN20723, Exp. Date Jun 2028; MN23223, Exp. Date Jul 2028; MN31123, Exp. Date Oct 2028; MN300524, MN300624 MN302624, MN302724, MN303324, Exp. Date Dec 2028."
}
]
}
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when FDA: Drug Recalls Class II publishes new changes.